Step 3: Protocol design and prescription Based on the consultation and labs, we design the protocol: which peptide or combination, dosing, cycle length, and the supplies needed
What the Research on BPC-157 Actually Shows Most of the evidence behind BPC-157 is preclinical, meaning the bulk of the research comes from animal studies, specifically on rats, or studies on cells in a lab
The existing literature suggests that while these agents may help optimize metabolic and surgical outcomes, their effects on bone remain highly context-dependent, influenced by factors such as age, baseline bone health, duration of therapy, and degree of weight loss
Ensuring quality, safety, and effectiveness is vital